Oxycodone Drugs Market Size, Share, and Trends 2025 to 2034

The global oxycodone drugs market is projected to expand from USD 7.06 billion in 2025 to approximately USD 11.53 billion by 2034, growing at a CAGR of 5.61%. North America led the market in 2024, driven by a high prevalence of chronic pain conditions and aging demographics. The market benefits from increasing approvals of abuse-deterrent formulations and continued demand for opioid-based pain relief.

Last Updated : July 2025  |  Report Code : 4125  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Oxycodone Drugs Market 

5.1. COVID-19 Landscape: Oxycodone Drugs Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Oxycodone Drugs Market, By Product Type

8.1. Oxycodone Drugs Market Revenue and Volume, by Product Type

8.1.1 Short-acting

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Long acting

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Oxycodone Drugs Market, By Distribution Channel

9.1. Oxycodone Drugs Market Revenue and Volume, by Distribution Channel

9.1.1. Hospital Pharmacies

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Retail Pharmacies

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Online Pharmacies

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Oxycodone Drugs Market, By March 

10.1. Oxycodone Drugs Market Revenue and Volume, by March

10.1.1. Consumer

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Automotive

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Industrial

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Cheese

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Oxycodone Drugs Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Distribution Channel

11.1.3. Market Revenue and Volume Forecast, by March

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel

11.1.4.3. Market Revenue and Volume Forecast, by March

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Distribution Channel

11.1.5.3. Market Revenue and Volume Forecast, by March

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Distribution Channel

11.2.3. Market Revenue and Volume Forecast, by March

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel

11.2.4.3. Market Revenue and Volume Forecast, by March

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel

11.2.5.3. Market Revenue and Volume Forecast, by March

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel

11.2.6.3. Market Revenue and Volume Forecast, by March

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Distribution Channel

11.2.7.3. Market Revenue and Volume Forecast, by March

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Distribution Channel

11.3.3. Market Revenue and Volume Forecast, by March

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel

11.3.4.3. Market Revenue and Volume Forecast, by March

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel

11.3.5.3. Market Revenue and Volume Forecast, by March

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel

11.3.6.3. Market Revenue and Volume Forecast, by March

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Distribution Channel

11.3.7.3. Market Revenue and Volume Forecast, by March

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Distribution Channel

11.4.3. Market Revenue and Volume Forecast, by March

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel

11.4.4.3. Market Revenue and Volume Forecast, by March

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel

11.4.5.3. Market Revenue and Volume Forecast, by March

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel

11.4.6.3. Market Revenue and Volume Forecast, by March

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Distribution Channel

11.4.7.3. Market Revenue and Volume Forecast, by March

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Distribution Channel

11.5.3. Market Revenue and Volume Forecast, by March

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel

11.5.4.3. Market Revenue and Volume Forecast, by March

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Distribution Channel

11.5.5.3. Market Revenue and Volume Forecast, by March

Chapter 12. Company Profiles

12.1. Teva Pharmaceutical Industries Ltd

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Endo Pharmaceuticals Inc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Collegium Pharmaceutical Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Mallinckrodt Pharmaceuticals

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Sun Pharmaceutical Industries Ltd

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global oxycodone drugs market size is expected to increase USD 11.53 billion by 2034 from USD 6.68 billion in 2024.

The global oxycodone drugs market will register growth rate of 5.61% between 2025 and 2034.

The major players operating in the oxycodone drugs market are Teva Pharmaceutical Industries Ltd, Endo Pharmaceuticals Inc, Collegium Pharmaceutical Inc, Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd, and Others.

The driving factors of the oxycodone drugs market are the rise in the incidence of chronic pain diseases and increasing frequency of long-term illnesses that need pain management.

North America region will lead the global oxycodone drugs market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client